Literature DB >> 9339961

Practical recommendations for the treatment of ascites and its complications.

R Bataller1, P Ginès, V Arroyo.   

Abstract

Ascites is one of the earliest and most common complications of patients with cirrhosis, and is associated with complications such as dilutional hyponatraemia, renal dysfunction and spontaneous bacterial peritonitis. The treatment of ascites has been based on the combination of a low-sodium diet and the administration of diuretics. The reintroduction of paracentesis and the recent introduction of the transjugular intrahepatic portosystemic shunt (TIPS) are the most relevant innovations in the treatment of ascites during the past 2 decades. The development of ascites is closely related to renal disturbances of functional origin, including the hepatorenal syndrome. A new definition of hepatorenal syndrome has been proposed recently and 2 different types have been defined (type I or progressive, and type III or stable). Although no effective therapy exists for this syndrome, the use of therapeutic methods (TIPS, vasoconstrictor agents, dialysis) to temporarily improve renal function and act as a 'bridge' to liver transplantation, may be of most benefit. The use of potent and safe antibiotics has improved the resolution rate and survival of patients with spontaneous bacterial peritonitis. In addition, the use of oral antibiotics will simplify the management of this condition in the near future. Finally, prophylactic antibiotic regimens represent a major step forwards in the prevention of spontaneous bacterial peritonitis in subsets of cirrhotic patients with a great risk of developing this complication.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9339961     DOI: 10.2165/00003495-199754040-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  45 in total

1.  Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.

Authors:  M Novella; R Solà; G Soriano; M Andreu; J Gana; J Ortiz; S Coll; M Sàbat; M C Vila; C Guarner; F Vilardell
Journal:  Hepatology       Date:  1997-03       Impact factor: 17.425

2.  Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with ascites: a meta-analysis.

Authors:  B Bernard; J D Grangé; E N Khac; X Amiot; P Opolon; T Poynard
Journal:  Digestion       Date:  1998-07       Impact factor: 3.216

3.  Treatment of patients with cirrhosis and refractory ascites using LeVeen shunt with titanium tip: comparison with therapeutic paracentesis.

Authors:  A Ginès; R Planas; P Angeli; C Guarner; F Salerno; P Ginès; J Saló; N Rodriguez; E Domènech; G Soriano
Journal:  Hepatology       Date:  1995-07       Impact factor: 17.425

4.  Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention.

Authors:  M Bosch-Marcé; W Jiménez; P Angeli; A Leivas; J Clària; A Graziotto; V Arroyo; F Rivera; J Rodés
Journal:  Gastroenterology       Date:  1995-07       Impact factor: 22.682

5.  Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters.

Authors:  J Quiroga; B Sangro; M Núñez; I Bilbao; J Longo; L García-Villarreal; J M Zozaya; M Betés; J I Herrero; J Prieto
Journal:  Hepatology       Date:  1995-04       Impact factor: 17.425

6.  The treatment of the hepatorenal syndrome with intra-renal administration of prostaglandin E1.

Authors:  R M Zusman; L Axelrod; N Tolkoff-Rubin
Journal:  Prostaglandins       Date:  1977-05

7.  The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.

Authors:  A Ochs; M Rössle; K Haag; K H Hauenstein; P Deibert; V Siegerstetter; M Huonker; M Langer; H E Blum
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

8.  Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial.

Authors:  A Rolachon; L Cordier; Y Bacq; J B Nousbaum; A Franza; J C Paris; S Fratte; B Bohn; P Kitmacher; J P Stahl
Journal:  Hepatology       Date:  1995-10       Impact factor: 17.425

9.  Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study.

Authors:  P Ginés; V Arroyo; E Quintero; R Planas; F Bory; J Cabrera; A Rimola; J Viver; J Camps; W Jiménez
Journal:  Gastroenterology       Date:  1987-08       Impact factor: 22.682

10.  Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections.

Authors:  J Felisart; A Rimola; V Arroyo; R M Perez-Ayuso; E Quintero; P Gines; J Rodes
Journal:  Hepatology       Date:  1985 May-Jun       Impact factor: 17.425

View more
  1 in total

1.  Effect of albumin-furosemide mixtures on response to furosemide in cirrhotic patients with ascites.

Authors:  D C Brater; N Chalasani; J C Gorski; J C Horlander; R Craven; H Hoen; J Maya
Journal:  Trans Am Clin Climatol Assoc       Date:  2001
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.